On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
Moderna (NASDAQ:MRNA) earlier projected revenues for fiscal year 2025 to settle between $1.5 billion and $2.5 billion. While recognizing that products in Moderna’s pipeline could contribute to ...
Zacks Small Cap Research on MSN3d
DYAI: Looking Toward Product Revenues
DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...
Enzymes are a vital tool that make in vitro transcription possible and refine the reaction products to generate highly pure, homogeneous mRNA. In this ebook, we provide an in-depth review into: The ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...
In mRNA manufacturing, it helps ensure the purity and quality of the final mRNA product. Dyadic’s C1 produced DNAse1 holds a certificate of analysis and the product is ready for non-GMP ...